Primary Practice Areas:
Industry Focus:
Education:
- The Catholic University of America, Ph.D., Roland M. Nardone Award: Excellence in Teaching Assistance, Cellular and Microbial Biology
- The Franciscan University of Steubenville, B.A., summa cum laude, Biology and Theology
Bar Admissions:
- United States Patent and Trademark Office (USPTO)
Languages:
- English
Dr. Stephany G. Small focuses her practice on acquiring and preserving intellectual property rights in all areas of life science, including biologics, pharmaceuticals, treatment/diagnostic methods, novel plant varieties, and transgenic plants. Her practice involves procurement of patents through prosecution before the U.S. Patent and Trademark Office and foreign jurisdictions and also involves litigation matters including proceedings before the Patent Trial and Appeal Board (PTAB).
Dr. Stephany G. Small works with clients ranging from large life science companies to individual inventors to protect their valued intellectual property. Her in-house experience coupled with her extensive life science research background equips her to provide clients with technical expertise and comprehensive strategy guidance.
With a Ph.D. in cellular and microbial biology from The Catholic University of America, Stephany focuses her practice on the life sciences fields, including biologics, pharmaceuticals, treatment methods, novel plant varieties, transgenic plants, and diagnostic testing methods/apparatus. With more than seven years of life science research experience, particularly into genetics and molecular biology, along with extensive course work, Stephany is well versed in the biological and chemical arts.
Before moving into private practice, Stephany gained valuable experience working in-house at a biopharmaceutical corporation that developed therapeutic monoclonal antibodies. Her work highlighted the important relationship between intellectual property and business development, marketing, and regulation.
Stephany prepares and prosecutes U.S. and foreign patent applications for inventions related to all aspects of life science. She is involved in FDA Orange Book submissions and Patent Term Extension Applications, and also assists clients with preparing opinions relating to patentability and freedom to operate. Stephany collaborates in patent interferences and inter partes review proceedings before the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB).
Stephany provides her clients with sophisticated strategies rooted in scientific analysis for obtaining and preserving intellectual property. Her scientific knowledge and experience, along with her proven abilities in communicating science to diverse audiences, help her to help her clients accomplish their goals.
Stephany’s representative interference experience includes:
- Andersen v. Wan, Patent Interference No. 106,002, USPTO Patent Trial and Appeal Board
- Broad Institute, Inc., et al. v. Regents of the Univ. of Calif., et al., Patent Interference No. 106,048 (Patent Interference relating to CRISPR-CAS9 gene editing technology before USPTO PTAB)
Stephany’s representative IPR experience includes:
- Varian Medical Systems, Inc. v. Best Medical International, Inc., IPR2020-00053
- Varian Medical Systems, Inc. v. Best Medical International, Inc., IPR2020-00076
- Varian Medical Systems, Inc. v. Best Medical International, Inc., IPR2020-00077
- Elekta Inc. v. Best Medical International, Inc., IPR2020-00067
- Elekta Inc. v. Best Medical International, Inc., IPR2020-00073
- 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00154, USPTO Patent Trial and Appeal Board
- 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00155, USPTO Patent Trial and Appeal Board
- 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00156, USPTO Patent Trial and Appeal Board
- 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00157, USPTO Patent Trial and Appeal Board
- 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00159, USPTO Patent Trial and Appeal Board
- 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00160, USPTO Patent Trial and Appeal Board
- 3Shape A/S et al. v. Align Technology, Inc., IPR2019-00163, USPTO Patent Trial and Appeal Board
- Google LLC et al. v. Space Data Corporation, IPR2018-00944, USPTO Patent Trial and Appeal Board
- Google LLC et al. v. Space Data Corporation, IPR2018-00945, USPTO Patent Trial and Appeal Board
- Google LLC et al. v. Space Data Corporation, IPR2018-00946, USPTO Patent Trial and Appeal Board
- Google LLC et al. v. Space Data Corporation, IPR2018-00947, USPTO Patent Trial and Appeal Board
- Align Technology, Inc. v. 3Shape A/S, IPR2018-0195, USPTO Patent Trial and Appeal Board
- Align Technology, Inc. v. 3Shape A/S, IPR2018-0196, USPTO Patent Trial and Appeal Board
- Align Technology, Inc. v. 3Shape A/S, IPR2018-0197, USPTO Patent Trial and Appeal Board
- Align Technology, Inc. v. 3Shape A/S, IPR2018-0198, USPTO Patent Trial and Appeal Board
When not at work, Stephany enjoys cycling with her husband and two children. To raise funds for charity, she and her husband once biked from New York City to Washington, D.C. over the course of five days, and she also has cycled in a century (100-mile) ride.
- Panitch Schwarze Team Members to Discuss Patent Eligibility at American Chemical Society Fall 2022 Conference
August 22, 2022Date & Time: Monday, August 22, 2022 at 2:00 PM CDT Location: McCormick Place Convention Center, 2301 S King Dr,…
- Panitch Schwarze Team Members to Discuss Intellectual Property Rights at AmericanHort Cultivate’22 Conference
July 18, 2022Date & Time: Monday, July 18th, 2022 at 1:30 p.m. EDT and Tuesday, July 19th, 2022 at 11 a.m. EDT…
- USTPO New File Sequence Listing Requirements
July 1, 2022All applications with a filing date or international filing date on or after July 1, 2022, MUST file sequence listings…
- Panitch Schwarze Patent Agent Stephany G. Small, Ph.D. Discusses Plant Patents with Nursery Management Magazine
June 28, 2022Panitch Schwarze patent agent Stephany G. Small, Ph.D. recently discussed different types of intellectual property protection available for plants in…
- Brazilian Supreme Court Decides All Patents Receive Patent Term of 20 Years
May 26, 2021Recent decisions by the Brazilian Supreme Court removed the option of patent term extension and retroactively changed the patent term…